The Patent Finder

Versi Group, LLC

Also on record
Records under this name other than patents Versi Group, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Versi Group, LLC

PatentTitleStatus Expires Confidence
US 8,029,496Method and device for delivering drug to the trigone of the bladder
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,973,815Delta opioid agonist mu opioid antagonist compositions and methods for treating Parkinsons disease
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,779,581Opioid for use to reduce and/or treat drug addiction
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,071,093Method of Treating Parkinson's Disease with a Diarylmethylpiperazine Compounds Exhibiting Delta Opioid Receptor Agonist Activity
Formerly held
Term ended
Term ended Sep 5, 2026 · High confidence
Term endedTerm ended Sep 5, 2026High confidence
US 11,246,865Opioid for use to reduce and/or treat drug addiction
Formerly held
Lapsed on the fee record
Ended Feb 15, 2026 · From the USPTO record
Lapsed on the fee recordEnded Feb 15, 2026From the USPTO record
US 8,642,599Method of Treating Parkinson's Disease with Diarylmethylpiperazine Compounds Exhibiting Delta Receptor Agonist Activity
Formerly held
Lapsed on the fee record
Ended Feb 4, 2026 · High confidence
Lapsed on the fee recordEnded Feb 4, 2026High confidence
US 9,701,645Method of Treating Parkinson's Disease with a Diarylmethylpiperazine Compounds Exhibiting Delta Opioid Receptor Agonist Activity
Formerly held
Lapsed on the fee record
Ended Jul 11, 2025 · High confidence
Lapsed on the fee recordEnded Jul 11, 2025High confidence
US 6,924,288Enantiomerically pure opioid diarylmethylpiperzine and methods of using same
Formerly held
Term ended
Term ended May 1, 2023 · From the USPTO record
Term endedTerm ended May 1, 2023From the USPTO record
US 8,865,721Delta opioid receptor agonist compounds
Formerly held
Lapsed on the fee record
Ended Oct 21, 2022 · From the USPTO record
Lapsed on the fee recordEnded Oct 21, 2022From the USPTO record
US 7,189,725Enantiomerically pure opioid diarylmethylpiperazine as a cardioprotection agent
Formerly held
Term ended
Term ended Oct 8, 2022 · From the USPTO record
Term endedTerm ended Oct 8, 2022From the USPTO record
10 of 22 patents shown.
Pro members see all 22.
Pro members: see all 22 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited